Physician profile
Ralph D Brown
NPI 1215916556
$2,381.88
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $505 · 2021: $461 · 2022: $418 · 2023: $156 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $467.03 | 2019-2022 | |
| Abbvie INC. | $339.61 | 2021-2024 | Botox, Qulipta |
| Teva Pharmaceuticals USA, INC. | $325.80 | 2019-2022 | |
| Smith+Nephew, INC. | $167.11 | 2019-2022 | |
| Lilly USA, LLC | $135.34 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $126.15 | 2019-2021 | |
| Amgen INC. | $122.01 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $106.91 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $97.21 | 2023-2024 | Rexulti, Nuedexta |
| Pacira Therapeutics, INC. | $64.79 | 2019-2020 | |
| Pfizer INC. | $51.50 | 2019-2021 | |
| Bioventus LLC | $39.06 | 2022-2024 | Durolane |
| Integra Lifesciences Corporation | $36.62 | 2019-2020 | |
| Kci USA, INC. | $36.27 | 2020-2021 | |
| Hydrofera LLC | $35.25 | 2024 | Hydrofera Blue |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $30.27 | 2020-2022 | |
| Acell, INC. | $26.09 | 2019 | |
| Organogenesis INC. | $21.73 | 2019 | |
| Eisai INC. | $20.74 | 2021 | |
| Axsome Therapeutics, INC. | $20.50 | 2023 | Sunosi |
| E.R. Squibb & Sons, L.L.C. | $18.93 | 2021 | |
| Osiris Therapeutics INC. | $17.44 | 2019 | |
| Coloplast Corp | $17.42 | 2019 | |
| Lundbeck LLC | $16.89 | 2022 | |
| Ibsa Pharma INC. | $14.04 | 2021 | |
| Grt US Holding, INC. | $14.02 | 2021 | |
| Shionogi INC | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.